Middle East & Africa RT-PCR Market Analysis and Forecast by Size, Share, Growth, Trends 2031

The Middle East and Africa RT-PCR Market size is expected to reach US$ 276.3 Million by 2031 from US$ 178.2 Million in 2024. The market is estimated to record a CAGR of 6.6% from 2025 to 2031.

Executive Summary and Middle East and Africa RT-PCR Market Analysis:

The RT-PCR market in Middle East & Africa is driven by the continued circulation of SARS-CoV-2, active surveillance by several countries, and sustained demand for molecular diagnostics. According to WHO regional surveillance reports, during four weeks in late 2024, test positivity in the African region rose from nearly 1.4% to 4.4%, indicating renewed viral activity. Similarly, in mid-2024, sentinel surveillance in several African countries observed isolated spikes; for example, in one reporting period, weekly positivity in at least one country increased from 3.3% to 7.1%.

In 2023, the WHO African Region reported a total of nearly 10.8 million confirmed COVID-19 cases and 228,738 deaths, underlining a substantial ongoing burden even after earlier global waves. Additionally, peer-reviewed research has documented that a large number of SARS-CoV-2 infections remain under-detected in sub-Saharan Africa, and that routine virological surveillance (PCR-based) remains essential for understanding transmission dynamics across 45 countries.

Scientific reviews highlight that despite vaccine rollouts and seroprevalence, the emergence of new variants globally demands updated, high sensitivity RT PCR assays to reliably detect infections, especially in low-resource settings where rapid diagnostics remain critical.

Middle East & Africa RT-PCR Market: Strategic Insights

Middle East and Africa RT-PCR Market Segmentation Analysis:

• By Product, the Middle East and Africa RT-PCR Market is segmented into Reagents and Consumables, Instruments, and Software and Services. The Reagents and Consumables segment dominated the market in 2024.
• By Application, the Middle East and Africa RT-PCR Market is segmented into Research Application, Clinical Application, and Forensic Application. The Clinical Application segment dominated the market in 2024.
• By Clinical Application, the Middle East and Africa RT-PCR Market is segmented into Oncology testing, Blood Screening, Infectious Disease Testing, and Other Applications. The Infectious Disease Testing segment dominated the market in 2024.
• By End User, the Middle East and Africa RT-PCR Market is segmented into Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories, and Clinical Research Organizations. The Hospitals and Diagnostic Centers segment dominated the market in 2024.

Middle East & Africa RT-PCR Market Players Density: Understanding Its Impact on Business Dynamics

The Middle East & Africa RT-PCR Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Middle East and Africa RT-PCR Market Outlook

A prominent trend in the global RT-PCR market is the rising adoption of multiplex RT-PCR assays, which can detect multiple pathogens simultaneously in a single test. This approach enhances diagnostic efficiency, reduces costs, and accelerates diagnosis, especially during overlapping outbreaks. According to the CDC's 2023 report, multiplex assays have been increasingly used in the US to differentiate between COVID-19, influenza, and RSV, which often present similar symptoms. The demand for these tests surged between 2022 and 2024, as the simultaneous circulation of influenza and SARS-CoV-2 created significant diagnostic challenges. Recent product developments, such as the CDC's multiplex panel approved in 2023, enable the simultaneous detection of up to six respiratory pathogens, streamlining clinical workflows. In Europe, companies such as Qiagen and Thermo Fisher launched new multiplex kits in 2023, tailored for rapid diagnostics. This shift toward multiplexing reflects a broader trend to enhance diagnostic accuracy and preparedness for future pandemics.

Middle East and Africa RT-PCR Market Country Insights

By country, the Middle East and Africa RT-PCR Market is segmented into Saudi Arabia, South Africa, the United Arab Emirates, and the Rest of Middle East and Africa. Saudi Arabia held the largest share in 2024.

The Saudi Arabia RT-PCR market continues to grow because RT-PCR remains central to diagnosing and monitoring key infectious diseases and supporting public health surveillance. During the COVID-19 pandemic, Saudi Arabia conducted over 45 million PCR tests by early 2024, reflecting sustained diagnostic activity beyond initial outbreak peaks and an ongoing commitment to disease control using molecular testing. According to the World Health Organization, as of 6 March 2024, Saudi Arabia reported 841,469 confirmed COVID-19 cases and 45,484,848 PCR tests conducted across the population. This extensive testing effort underscores how RT-PCR infrastructure has been built and maintained at a national level. Additionally, endemic diseases such as Middle East Respiratory Syndrome Coronavirus (MERS-CoV) continue to be identified through RT-PCR, with multiple confirmed cases reported between 2022 and 2024, demonstrating the ongoing need for precise molecular diagnostics in tracking and managing emerging infections. For example, WHO data shows MERS-CoV cases confirmed by RT-PCR between late 2023 and early 2024 and continuing into 2025, highlighting persistent surveillance requirements.

Middle East and Africa RT-PCR Market Company Profiles

Some of the key players operating in the market include Abbott Laboratories, F. Hoffmann-La Roche Ltd, bioMerieux SA, Bio-Rad Laboratories Inc, QIAGEN NV, Hologic Inc, Agilent Technologies Inc, Promega Corp, Takara Bio Inc, and Thermo Fisher Scientific Inc.

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Middle East and Africa RT-PCR Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise